119 related articles for article (PubMed ID: 17621553)
41. Syk tyrosine kinase participates in beta1-integrin signaling and inflammatory responses in airway epithelial cells.
Ulanova M; Puttagunta L; Marcet-Palacios M; Duszyk M; Steinhoff U; Duta F; Kim MK; Indik ZK; Schreiber AD; Befus AD
Am J Physiol Lung Cell Mol Physiol; 2005 Mar; 288(3):L497-507. PubMed ID: 15557085
[TBL] [Abstract][Full Text] [Related]
42. Dectin-1/Syk signaling is involved in Lactobacillus casei cell wall extract-induced mouse model of Kawasaki disease.
Lin IC; Suen JL; Huang SK; Huang SC; Huang HC; Kuo HC; Wei CC; Wang FS; Yu HR; Yang KD
Immunobiology; 2013 Feb; 218(2):201-12. PubMed ID: 22633994
[TBL] [Abstract][Full Text] [Related]
43. Anti-inflammatory effect of tetrahydrocoptisine from Corydalis impatiens is a function of possible inhibition of TNF-α, IL-6 and NO production in lipopolysaccharide-stimulated peritoneal macrophages through inhibiting NF-κB activation and MAPK pathway.
Li W; Huang H; Zhang Y; Fan T; Liu X; Xing W; Niu X
Eur J Pharmacol; 2013 Sep; 715(1-3):62-71. PubMed ID: 23810685
[TBL] [Abstract][Full Text] [Related]
44. The SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDL.
Miller YI; Choi SH; Wiesner P; Bae YS
Br J Pharmacol; 2012 Nov; 167(5):990-9. PubMed ID: 22776094
[TBL] [Abstract][Full Text] [Related]
45. The role of Syk signaling in antifungal innate immunity of human corneal epithelial cells.
Liu Y; Zhao G; Lin J; Li C; Li Q; Che C; Wang Q; Hu L
BMC Ophthalmol; 2015 Jun; 15():55. PubMed ID: 26036769
[TBL] [Abstract][Full Text] [Related]
46. Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinase-dependent pathways.
Li B; Cramer D; Wagner S; Hansen R; King C; Kakar S; Ding C; Yan J
Clin Immunol; 2007 Aug; 124(2):170-81. PubMed ID: 17572156
[TBL] [Abstract][Full Text] [Related]
47. [Involvement of Syk in pathology of systemic autoimmune disease].
Iwata S; Yamaoka K; Niiro H; Nakano K; Wang SP; Saito K; Akashi K; Tanaka Y
Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(1):56-61. PubMed ID: 22374444
[TBL] [Abstract][Full Text] [Related]
48. Induced Syk deletion leads to suppressed allergic responses but has no effect on neutrophil or monocyte migration in vivo.
Wex E; Bouyssou T; Duechs MJ; Erb KJ; Gantner F; Sanderson MP; Schnapp A; Stierstorfer BE; Wollin L
Eur J Immunol; 2011 Nov; 41(11):3208-18. PubMed ID: 21830208
[TBL] [Abstract][Full Text] [Related]
49. IL-21 enhances phagocytosis in mononuclear phagocyte cells: identification of spleen tyrosine kinase as a novel molecular target of IL-21.
Vallières F; Girard D
J Immunol; 2013 Mar; 190(6):2904-12. PubMed ID: 23396946
[TBL] [Abstract][Full Text] [Related]
50. Getting Syk: spleen tyrosine kinase as a therapeutic target.
Geahlen RL
Trends Pharmacol Sci; 2014 Aug; 35(8):414-22. PubMed ID: 24975478
[TBL] [Abstract][Full Text] [Related]
51. The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-β secretion from monocytes/macrophages through the DAP12-Syk pathway.
Takamiya R; Ohtsubo K; Takamatsu S; Taniguchi N; Angata T
Glycobiology; 2013 Feb; 23(2):178-87. PubMed ID: 23035012
[TBL] [Abstract][Full Text] [Related]
52. Involvement of Src and Syk tyrosine kinases in HIV-1 transfer from dendritic cells to CD4+ T lymphocytes.
Gilbert C; Barat C; Cantin R; Tremblay MJ
J Immunol; 2007 Mar; 178(5):2862-71. PubMed ID: 17312130
[TBL] [Abstract][Full Text] [Related]
53. Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor.
Pine PR; Chang B; Schoettler N; Banquerigo ML; Wang S; Lau A; Zhao F; Grossbard EB; Payan DG; Brahn E
Clin Immunol; 2007 Sep; 124(3):244-57. PubMed ID: 17537677
[TBL] [Abstract][Full Text] [Related]
54. A Novel Triazolopyridine-Based Spleen Tyrosine Kinase Inhibitor That Arrests Joint Inflammation.
Ferguson GD; Delgado M; Plantevin-Krenitsky V; Jensen-Pergakes K; Bates RJ; Torres S; Celeridad M; Brown H; Burnett K; Nadolny L; Tehrani L; Packard G; Pagarigan B; Haelewyn J; Nguyen T; Xu L; Tang Y; Hickman M; Baculi F; Pierce S; Miyazawa K; Jackson P; Chamberlain P; LeBrun L; Xie W; Bennett B; Blease K
PLoS One; 2016; 11(1):e0145705. PubMed ID: 26756335
[TBL] [Abstract][Full Text] [Related]
55. Multimolecular signaling complexes enable Syk-mediated signaling of CD36 internalization.
Heit B; Kim H; Cosío G; Castaño D; Collins R; Lowell CA; Kain KC; Trimble WS; Grinstein S
Dev Cell; 2013 Feb; 24(4):372-83. PubMed ID: 23395392
[TBL] [Abstract][Full Text] [Related]
56. Syk: a novel target for treatment of inflammation in lung disease.
Sanderson MP; Lau CW; Schnapp A; Chow CW
Inflamm Allergy Drug Targets; 2009 Jun; 8(2):87-95. PubMed ID: 19530990
[TBL] [Abstract][Full Text] [Related]
57. Syk inhibitor R406 downregulates inflammation in an in vitro model of Pseudomonas aeruginosa infection.
Alhazmi A; Choi J; Ulanova M
Can J Physiol Pharmacol; 2018 Feb; 96(2):182-190. PubMed ID: 29020462
[TBL] [Abstract][Full Text] [Related]
58. Syk Inhibitor Attenuates Polymicrobial Sepsis in FcgRIIb-Deficient Lupus Mouse Model, the Impact of Lupus Characteristics in Sepsis.
Issara-Amphorn J; Chancharoenthana W; Visitchanakun P; Leelahavanichkul A
J Innate Immun; 2020; 12(6):461-479. PubMed ID: 32927460
[TBL] [Abstract][Full Text] [Related]
59. Syk promotes phagocytosis by inducing reactive oxygen species generation and suppressing SOCS1 in macrophage-mediated inflammatory responses.
Yi YS; Kim HG; Kim JH; Yang WS; Kim E; Park JG; Aziz N; Parameswaran N; Cho JY
Int J Immunopathol Pharmacol; 2022; 36():3946320221133018. PubMed ID: 36214175
[TBL] [Abstract][Full Text] [Related]
60. A peptide-based biosensor assay to detect intracellular Syk kinase activation and inhibition.
Lipchik AM; Killins RL; Geahlen RL; Parker LL
Biochemistry; 2012 Sep; 51(38):7515-24. PubMed ID: 22920457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
